Moberg Pharma AB (publ) logo

Moberg Pharma AB (publ)

SSE:MOB.ST

Overview | Financials
Company Name Moberg Pharma AB (publ)
Symbol MOB.ST
Currency SEK
Price 15.1
Market Cap 422,219,043
Dividend Yield 0%
52-week-range 4.133 - 22.8
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Kerstin Valinder Strinnholm
Website https://www.mobergpharma.se

An error occurred while fetching data.

About Moberg Pharma AB (publ)

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to

Related Stocks

IRRAS AB (publ) logo

IRRAS AB (publ)

IRRAS.ST

0.16 SEK

AroCell AB (publ) logo

AroCell AB (publ)

AROC.ST

0.405 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD